Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerNPI Medicare & MedicaidNPI 1457091324
    Ask Trek AI about this page

    NPI 1457091324 — Billing Profile & Reimbursement Data

    NPI 1457091324 · XX · healthcare

    Customize your policy alerts

    Sign up for NPI 1457091324 — Billing Profile & Reimbursement Data policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    NPI 1457091324 is a healthcare provider located in Unspecified Location. This profile covers 34 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services. Note: "XX" is a placeholder CMS uses when a provider's practice-location state wasn't reported — not a traditional US state; claims coded under it are grouped and benchmarked here the same way a traditional state would be.

    Provider details (source: NPPES NPI Registry)

    FieldValue
    Entity TypeIndividual
    OrganizationNPI 1457091324
    Address
    City
    StateXX (Unspecified Location)
    ZIP
    TaxonomyN/A
    NPI Enumerated
    NPI DeactivatedOctober 4, 2023

    (source: CMS Medicare & Medicaid claims data)

    Key Findings

    This provider’s billed Medicare volume is concentrated in a single payer channel: Total Medicare revenue is $5.6M while Total Medicaid revenue is none (no Medicaid billing on file), indicating the entity is effectively a Medicare-only biller in the available data rather than a dual-payer operator. The absence of Medicaid claims limits any Medicaid-level competitive or state-market analysis.

    Revenue is extremely concentrated in a very small set of Medicare codes: the precomputed top 3 Medicare codes by revenue account for 97.5% of this provider's total Medicare revenue, with a single code, K1034, contributing $5.4M (95.4% of Medicare revenue). Such concentration creates material revenue dependence on the policies and reimbursement dynamics affecting those few codes.

    K1034 (450.2K claims, $12 avg paid/claim, $5.4M revenue) dominates the provider’s Medicare picture and is a national outlier: it ranks #84 of 30143 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code). This pattern — very high claim volume at low average paid/claim — is consistent with large-scale distribution or provisioning of low-unit-cost items (nonprescription self-administered COVID-19 tests) rather than traditional episodic clinical services.

    Medicare: Total Revenue Breakdown by CPT/HCPCS Code

    Medicare revenue breakdown by CPT/HCPCS procedure code.

    View: Bar Chart1 / 2

    Medicare Revenue by CPT/HCPCS Code

    Medicare: Complete Services Breakdown

    The CPT/HCPCS codes generating the most Medicare revenue for this provider.

    34 rows

    CPT/HCPCS CodeDescriptionClaimsAvg PaidRevenue
    K1034Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count450,170$10$5.4M
    87798The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified…2,810$30$95.6K
    87481The lab analyst performs a test for Candida species using amplified nucleic acid probe technique.700$30$23.7K
    81317The lab analyst performs the technical lab test to analyze the entire gene sequence for the postmeiotic segregation increased 2 [S. cerevisiae], or PMS2 gene.20$660$11.9K
    81298The lab analyst performs the technical lab test to analyze the entire gene sequence for the mutS homolog 6 [E. coli], or MSH6 gene.20$630$11.3K
    87631The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,…80$140$11.2K
    81307The lab analyst performs the technical lab test on a specimen such as blood, to analyze the entire gene sequence for the partner and localizer of BRCA2 (PALB2) gene.10$660$9.3K
    81201The lab analyst performs the technical lab test to analyze the entire gene sequence for adenomatous polyposis coli, also known as APC.10$760$9.2K
    81238The lab analyst performs the technical lab test to analyze the full gene sequence of the coagulation factor IX (F9) gene.10$590$8.2K
    81249The lab analyst performs the technical lab test to analyze known the full gene sequence of the glucose–6–phosphate dehydrogenase (G6PD) gene.10$590$7.6K

    Showing 1–10 of 34

    Medicare: Competitive Analysis & Benchmarks

    How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 34 CPT/HCPCS codes. Note: this provider's state, "XX," is a placeholder CMS uses when a provider's practice-location state wasn't reported — not a traditional US state; the State panel below benchmarks against other providers coded under the same designation.

    View: State1 / 2

    Claims Volume vs. Unspecified Location Distribution
    NPI 1457091324 — 0 of 0 codes billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Rank Distribution — Unspecified Location

    Full comparison — all codes billed, vs. state median

    34 rows

    CPT/HCPCS CodeRankProvider CountMedian ClaimsAvg PaidAverage Revenue
    8120120N/A$N/A$N/A
    81209160N/A$N/A$N/A
    81223260N/A$N/A$N/A
    81238170N/A$N/A$N/A
    81242160N/A$N/A$N/A
    81249230N/A$N/A$N/A
    81250160N/A$N/A$N/A
    8129530N/A$N/A$N/A
    81298150N/A$N/A$N/A
    81307160N/A$N/A$N/A

    Showing 1–10 of 34

    Frequently Asked Questions

    References

    1. 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
    2. 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Table of contents

    Progress1 / 7

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools
    Lifetime revenue by payer source
    Payer SourceTotal Paid
    Medicare$5.6M
    Medicaid$0

    Beyond K1034, the provider bills a mix of amplified nucleic acid probe and multiplex respiratory test codes at modest volumes and revenues: 87798 (2.8K claims, $34 avg paid/claim, $95.6K revenue) ranks #313 of 1319 (76th percentile) and 87481 (698 claims, $34 avg paid/claim, $23.7K revenue) ranks #275 of 1117 (75th percentile). These positions indicate typical, unremarkable participation nationally for these lab testing services and suggest a secondary role in molecular diagnostic testing relative to the K1034 distribution activity.

    A suite of higher-paying genetic sequencing and specialty molecular codes appear on the provider’s file but generate only small absolute revenue and show low national standing: for example, 81317 (18 claims, $663 avg paid/claim, $11.9K revenue) ranks #45 of 51 (12th percentile) and 81298 (18 claims, $629 avg paid/claim, $11.3K revenue) ranks #44 of 50 (12th percentile). These entries signal niche, low-volume genetic testing activity that is not a primary revenue driver compared with the COVID test provisioning reflected by K1034.

    The provider’s coding mix highlights contrasting unit economics: very high volume, low-unit-price K1034 activity (450.2K claims at $12 avg paid/claim) produces the lion’s share of revenue, while specialty molecular and sequencing codes carry much higher average payments per claim (e.g., $663 or $764 avg paid/claim for several genetic tests) but trivial claim counts and aggregate dollars. This divergence implies operational emphasis on scale distribution for the dominant code and limited, likely opportunistic, utilization of high-reimbursement diagnostic tests.

    Because NPI enumerated (registered) status is unknown, tenure and enrollment history cannot be assessed from the supplied data; this limitation reduces certainty about how long the pattern of high K1034 volume has persisted. Analysts should treat the current snapshot as accurate for billed activity but corroborate provider enrollment records if historical participation or changes in payer contracts are material to downstream decisions.